205 related articles for article (PubMed ID: 27258612)
1. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets.
Maiga A; Lemieux S; Pabst C; Lavallée VP; Bouvier M; Sauvageau G; Hébert J
Blood Cancer J; 2016 Jun; 6(6):e431. PubMed ID: 27258612
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
[TBL] [Abstract][Full Text] [Related]
3. CD97 expression is associated with poor overall survival in acute myeloid leukemia.
Vaikari VP; Yang J; Wu S; Alachkar H
Exp Hematol; 2019 Jul; 75():64-73.e4. PubMed ID: 31260716
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.
de Jonge HJ; Woolthuis CM; Vos AZ; Mulder A; van den Berg E; Kluin PM; van der Weide K; de Bont ES; Huls G; Vellenga E; Schuringa JJ
Leukemia; 2011 Dec; 25(12):1825-33. PubMed ID: 21760593
[TBL] [Abstract][Full Text] [Related]
5. CD97 is a critical regulator of acute myeloid leukemia stem cell function.
Martin GH; Roy N; Chakraborty S; Desrichard A; Chung SS; Woolthuis CM; Hu W; Berezniuk I; Garrett-Bakelman FE; Hamann J; Devlin SM; Chan TA; Park CY
J Exp Med; 2019 Oct; 216(10):2362-2377. PubMed ID: 31371381
[TBL] [Abstract][Full Text] [Related]
6. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
7. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.
Tickenbrock L; Hehn S; Sargin B; Choudhary C; Bäumer N; Buerger H; Schulte B; Müller O; Berdel WE; Müller-Tidow C; Serve H
Int J Oncol; 2008 Dec; 33(6):1215-21. PubMed ID: 19020754
[TBL] [Abstract][Full Text] [Related]
8. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express Aurora kinase A.
Yang J; Ikezoe T; Nishioka C; Nobumoto A; Udaka K; Yokoyama A
Int J Cancer; 2013 Dec; 133(11):2706-19. PubMed ID: 23686525
[TBL] [Abstract][Full Text] [Related]
9. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
10. The role of polymorphisms of stromal-derived factor-1 and CXC receptor 4 in acute myeloid leukemia and leukemia cell dissemination.
Zheng Q; Shuai X; Ye Y; Jin Y; Jiang N; Chen X; Su J
Gene; 2016 Aug; 588(2):103-8. PubMed ID: 27154815
[TBL] [Abstract][Full Text] [Related]
11. [Maintenance of leukemic and normal hematopoietic stem cells in bone marrow niches by EVI1-regulated GPR56].
Saito Y; Morishita K
Rinsho Ketsueki; 2015 Apr; 56(4):375-83. PubMed ID: 25971267
[TBL] [Abstract][Full Text] [Related]
12. GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.
Pabst C; Bergeron A; Lavallée VP; Yeh J; Gendron P; Norddahl GL; Krosl J; Boivin I; Deneault E; Simard J; Imren S; Boucher G; Eppert K; Herold T; Bohlander SK; Humphries K; Lemieux S; Hébert J; Sauvageau G; Barabé F
Blood; 2016 Apr; 127(16):2018-27. PubMed ID: 26834243
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
14. An Overview on G Protein-coupled Receptor-induced Signal Transduction in Acute Myeloid Leukemia.
Selheim F; Aasebø E; Ribas C; Aragay AM
Curr Med Chem; 2019; 26(28):5293-5316. PubMed ID: 31032748
[TBL] [Abstract][Full Text] [Related]
15. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
16. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
17. International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors.
Hamann J; Aust G; Araç D; Engel FB; Formstone C; Fredriksson R; Hall RA; Harty BL; Kirchhoff C; Knapp B; Krishnan A; Liebscher I; Lin HH; Martinelli DC; Monk KR; Peeters MC; Piao X; Prömel S; Schöneberg T; Schwartz TW; Singer K; Stacey M; Ushkaryov YA; Vallon M; Wolfrum U; Wright MW; Xu L; Langenhan T; Schiöth HB
Pharmacol Rev; 2015; 67(2):338-67. PubMed ID: 25713288
[TBL] [Abstract][Full Text] [Related]
18. Expression of embryonic stem cell markers in acute myeloid leukemia.
Picot T; Aanei CM; Fayard A; Flandrin-Gresta P; Tondeur S; Gouttenoire M; Tavernier-Tardy E; Wattel E; Guyotat D; Campos L
Tumour Biol; 2017 Jul; 39(7):1010428317716629. PubMed ID: 28718379
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics.
Virtaneva K; Wright FA; Tanner SM; Yuan B; Lemon WJ; Caligiuri MA; Bloomfield CD; de La Chapelle A; Krahe R
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1124-9. PubMed ID: 11158605
[TBL] [Abstract][Full Text] [Related]
20. Helicase-like transcription factor is a RUNX1 target whose downregulation promotes genomic instability and correlates with complex cytogenetic features in acute myeloid leukemia.
Cheng CK; Chan NP; Wan TS; Lam LY; Cheung CH; Wong TH; Ip RK; Wong RS; Ng MH
Haematologica; 2016 Apr; 101(4):448-57. PubMed ID: 26802049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]